In their natural environment, bacteria engage in a continuous arms race as they compete for nutrients and physical space. The type 6 secretion system (T6SS) is a widely used weapon in the antibacterial arsenal of many Gram-negative species ([@r1][@r2]--[@r3]). The T6SS is a nanomachine capable of delivering toxic effector proteins into adjacent eukaryotic and bacterial cells ([@r4][@r5][@r6]--[@r7]). Mechanistically, the apparatus can be thought of as a spear gun that can, in an instant, plunge a poison-tipped spear into an adjacent target cell using mechanical energy captured during the assembly of the loaded gun. *Vibrio cholerae* T6SS is assembled in stages, starting with the formation of a transmembrane baseplate complex that anchors the apparatus to the cell envelope ([@r8]). This baseplate recruits a spearhead consisting of a trimer of VgrG subunits ([@r9]) and a PAAR-domain--containing tip protein ([@r10]). The baseplate and spearhead complex serve as the nucleation point for the assembly of the spear shaft, consisting of polymerized Hcp protein subunits ([@r11]). The toxic effectors of the T6SS associate with different components of this spear through interactions with PAAR proteins ([@r10]), VgrG ([@r12], [@r13]), Hcp proteins ([@r14]), or adapter proteins ([@r15], [@r16]). Finally, a sheath comprised of VipA and VipB subunits assembles around the Hcp tube in an extended conformation that produces a high-energy state ([@r17][@r18]--[@r19]). The sheath subunits can undergo a rapid conformational change resulting in contraction of the extended structure to propel the Hcp/VgrG/PAAR spear complex and their associated effectors out of the predatory T6SS^+^ cell and into adjacent target cells ([@r20]). Thus, the T6SS is considered a contact-dependent antibacterial machine although its absolute range of action has not been fully explored ([@r3]).

Many bacteria use the T6SS to gain a competitive advantage when growing in mixed-species biofilms. When a T6SS^+^ strain is grown in competition with a T6SS-sensitive strain, the growth of the sensitive strain is massively reduced in vitro ([@r5], [@r7], [@r21]) and in vivo ([@r22][@r23]--[@r24]). Unlike many other contact-dependent systems, most T6SSs characterized to date do not require a specific receptor in target cells to deliver toxic cargo or recognize prey cells. This property allows a bacterium using a single T6SS to attack a wide variety of target species. The T6SS of *V. cholerae* can target most Gram-negative cells and phagocytic eukaryotic cells ([@r7], [@r25]), but lacks potency against Gram-positive bacterial species, suggesting that a thick peptidoglycan layer can provide a barrier to T6SS effector delivery. The range of prey sensitivities to T6SS attack is not understood in molecular terms and there is little work that addresses the role of mechanical barriers in defense against T6SS attack. Along with versatility in target range within certain bacterial groups, such as Gram-negative organisms, the T6SS of most predatory species is associated with multiple effectors, each with distinct enzymatic activities that attack periplasmic as well as cytoplasmic target macromolecules ([@r10], [@r12], [@r26][@r27]--[@r28]). This multivalent character of the T6SS effector activity repertoire likely presents a difficult challenge for prey bacteria to evolve resistance against the individual effectors themselves.

Despite the robustness of the T6SS, some bacteria have evolved mechanisms to combat it. For example, *Pseudomonas aeruginosa* has evolved a unique regulatory mechanism of sensing exogenous T6SS attacks and assembling its own T6SS apparatus to launch a targeted retaliatory attack ([@r29]). In contrast, *Bacteroides* species in the human gut have acquired a large repertoire of resistance genes against various effectors, including those that they themselves do not express ([@r30]).

Because the T6SS is a contact-dependent system with a submicrometer range, another way for sensitive bacteria to evade killing is to avoid direct contact with T6SS-carrying bacteria. For example, planktonic bacteria floating in liquid culture do not engage in T6SS-dependent killing ([@r6], [@r7]). This physical separation of the bacteria prevents cells with a functional T6SS from reaching their susceptible target. Along similar lines, physical barriers between cells could provide an alternative form of resistance to T6SS killing, though no such barriers have been previously reported. In this study, we explored whether secreted exopolysaccharide (EPS) could serve as such a barrier. In *V. cholerae*, EPS is produced by the products of *vps* genes contained in two operons, VpsI and VpsII, encoding VpsA-K and VpsL-Q, respectively ([@r31]). When bacteria encounter a solid surface, they activate the expression of these Vps operons and begin secreting EPS, which helps cells adhere to surfaces and lays the foundation for additional matrix proteins to stabilize adhesion, resulting in biofilm formation ([@r32][@r33]--[@r34]).

Here we report that the EPS produced by *V. cholerae* can act as a type of "armor" to protect against T6SS attacks from different bacterial species. This armor does not affect the ability of the EPS-producing cell to use T6SS to attack other bacteria, indicating that EPS works to repel attacks rather than creating additional physical distance between cells. The effectiveness of the armor is tunable, as mutations that lead to up-regulation of EPS biosynthesis confer increased resistance to T6SS attacks. EPS-mediated resistance to T6SS attacks suggests a role for other EPSs in determining the outcomes of antagonistic bacterial--bacterial interactions that may have a profound influence on ecological and pathogenic success in microbial communities.

Results {#s1}
=======

To explore the impact of the physical barrier created by EPS on the T6SS, we constructed an in-frame deletion of the *vpsA* gene from the chromosome of *V. cholerae* V52, a strain that is constitutive for T6SS expression. *VpsA* encodes an essential component of the biosynthetic pathway involved in EPS production ([@r31]). Deletion of *vpsA* resulted in a marked reduction in biofilm formation for both wild-type and a T6SS knockout mutant carrying an in-frame deletion in *vasK* ([*SI Appendix*, Fig. S1*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1808469115/-/DCSupplemental)). However, visually under the microscope, the *vpsA* mutant was indistinguishable from the wild-type parent, with no measurable differences in cell-to-cell distance between the two strains. Additionally, deletion of *vpsA* did not significantly alter expression of T6SS genes in both the main and auxiliary gene clusters. We observed less than a twofold difference between the wild-type and *vpsA* knockout strains in T6SS transcripts from the main T6SS cluster compared with the nearly 20-fold reduced expression of the same genes when the T6SS structural gene *vasK* is knocked out ([*SI Appendix*, Fig. S1*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1808469115/-/DCSupplemental)). Furthermore, the *vpsA* mutant was clearly able to secrete Hcp in a T6SS-dependent manner at levels compared with a wild-type strain ([*SI Appendix*, Fig. S1*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1808469115/-/DCSupplemental)). These results indicate that the *vpsA* deletion does not significantly affect T6SS expression and functional secretion of its substrates.

The T6SS of *V. cholerae* is associated with three different effector--immunity pairs. When any of the immunity proteins are absent, the cells become susceptible to intoxication by the cognate effector protein delivered by the parental wild-type strain ([@r35]). We exploited this property to determine whether EPS could affect T6SS functionality in bacterial competition assays. By using isogenic predator and prey bacteria that were altered in T6SS effector and EPS genes, we were able to directly measure the effect of EPS production on the sensitivities of strains to T6SS attack. To make the prey strains sensitive to *V. cholerae* T6SS, we used knockouts of the operons encoding each of the T6SS effectors and their cognate immunity proteins: *vgrG3-tsiV3* (∆VCA0123-4) ([Fig. 1*A*](#fig01){ref-type="fig"}), the *tseL* operon (∆VC1417-21) ([Fig. 1*B*](#fig01){ref-type="fig"}), or the *vasX* operon (∆VCA0019-21) ([Fig. 1*C*](#fig01){ref-type="fig"}). The *vpsA* knockouts of each of these prey strains were cocultured with wild-type or *vpsA* knockout predators. Prey lacking *vpsA* were at least 100-fold more susceptible to killing than prey with functional EPS production (black vs. white columns, [Fig. 1](#fig01){ref-type="fig"}). In contrast, deletion of *vpsA* in the predator strain had no effect on T6SS-dependent killing for all three of the effectors tested ([Fig. 1](#fig01){ref-type="fig"}). Taken together, these results suggest that while the EPS produced by *V. cholerae* protects against exogenous T6SS attack, it does not prevent its own T6SS from efficiently attacking other bacterial cells.

![Deletion of *vpsA* in prey but not predator *V. cholerae* strains results in reduced T6SS-dependent killing. Wild-type and *vpsA* predator V52 were competed against prey V52 with and without deletion of *vpsA*. Prey stains were sensitive to (*A*) VgrG-3 (∆*vgrG-3*∆*tsiV3*), (*B*) TseL (∆*VC1417-21*), or (*C*) VasX (∆*VCA0019-21*). Data represent the mean ± SD of at least three biological replicates. Student's *t* test was performed to compare each condition (ns, *P* \> 0.05; \*\**P* ≤ 0.01; \*\*\**P* ≤ 0.001; \*\*\*\**P* \< 0.0001).](pnas.1808469115fig01){#fig01}

Because the protective property of EPS was not dependent on the specific effector sensitivity of the prey strain, we hypothesized that EPS was blocking the penetration of the exogenous secretion apparatus into the target EPS^+^ cell rather than providing a targeted defense against a particular effector activity. If this hypothesis is correct, we reasoned that EPS should also protect *V. cholerae* from T6SS attacks by heterologous organisms. We previously engineered *V. cholerae* V52 to deliver a chimeric VgrG protein carrying a nuclease domain from *Salmonella enterica* subsp*. arizonae* ([@r28]), allowing us to evaluate EPS protection against a non-*V. cholerae* effector. When competed against this isogenic predator, the V52 bacteria lacking *vpsA* were 10-fold more susceptible to T6SS killing than its wild-type EPS^+^ parent ([Fig. 2*A*](#fig02){ref-type="fig"}), indicating that EPS-mediated protection is likely not dependent on effector type when scored between homologous cells of the same bacterial species.

![EPS protects *V. cholerae* against T6SS attacks from heterologous organisms. (*A*) Competition between *V. cholerae* V52 expressing the chimeric VgrG3-NucSe1 nuclease effector from *S. enterica* subsp. *arizonae* and T6SS^−^ V52*vasK*, with or without the *vpsA* deletion. (*B*) Competition between *A. baylyi* ADP1 and T6SS^−^ V52*vasK*, with and without the *vpsA* deletion. (*C*) Competition between *P. aeruginosa* PAO1 and T6SS^+^ V52 and T6SS^−^ V52*vasK*, each with or without the *vpsA* deletion. (*D*) Competition between T6SS^+^ V52 and T6SS^−^ V52*vasK*, each with or without the *vpsA* deletion, against *E. coli* MG1655. Data represent the mean ± SD of three biological replicates. Student's *t* test was performed to compare each condition (ns, *P* \> 0.05; \**P* ≤ 0.05; \*\**P* ≤ 0.01).](pnas.1808469115fig02){#fig02}

We also evaluated the impact of EPS in cross-species interactions by coculturing the *vpsA* mutant and its isogenic parent with *Acinetobacter baylyi* ADP1. We used a T6SS^−^ mutant of V52 (deleted in *vasK*) as prey to avoid complications arising from killing of the *A. baylyi* predator by the T6SS of the *V. cholerae* prey. We found that the *vpsA* mutant of V52 *vasK* was 10-fold more susceptible to *A. baylyi* killing than its EPS^+^ wild-type parent ([Fig. 2*B*](#fig02){ref-type="fig"}).

*P. aeruginosa* has a unique posttranslational regulatory mechanism that allows it to assemble and fire its T6SS with precision at cells that attack the *P. aeruginosa* with their own T6SS ([@r29]). As such, killing of *V. cholerae* by the *P. aeruginosa* T6SS reflects both *V. cholerae* T6SS activity and the sensitivity of *V. cholerae* to the *P. aeruginosa* T6SS counterattack. We found that *V. cholerae* carrying the *vpsA* deletion were 100-fold more sensitive to killing by *P. aeruginosa* (black bars, [Fig. 2*C*](#fig02){ref-type="fig"}). In contrast, *V. cholerae* lacking a functional T6SS were not killed by *P. aeruginosa*, regardless of whether they carried the *vpsA* mutation or not (white bars, [Fig. 2*C*](#fig02){ref-type="fig"}). In homologous species competitions, EPS production by *V. cholerae* strains acting as predators had no effect on T6SS activity directed against T6SS-sensitive *V. cholerae* ([Fig. 1](#fig01){ref-type="fig"}). EPS production also did not affect predatory activity directed against a heterologous species, *Escherichia coli* MG1655, in that this strain was equally susceptible to killing by both wild-type and *vpsA* mutant *V. cholerae* (black bars, [Fig. 2*D*](#fig02){ref-type="fig"}). These data suggest that the increased killing by the *P. aeruginosa* T6SS was indeed due to increased sensitivity of *V. cholerae vpsA* mutants to *P. aeruginosa* T6SS counterattacks rather than the ability of VPS mutants to induce more counterattacks through better T6SS function. Stated another way, we saw no evidence that T6SS^+^ EPS^−^ mutants carry out more efficient attacks on prey and thus induced more lethal counterattacks by *P. aeruginosa*. Rather, EPS simply blocks counterattacks that occur with similar frequencies when *P. aeruginosa* encounters either a wild-type or EPS mutant that has a functional T6SS.

Having observed a protective effect of EPS, we evaluated whether other components of the biofilm matrix could also contribute to T6SS armor. We constructed strains with deletions in the *rbmA*, *rbmC*, and *bap1* genes, which are essential for mature biofilm formation and integrity ([@r33], [@r36][@r37]--[@r38]). Deletions of these matrix genes did not alter T6SS-dependent Hcp secretion ([Fig. 3*A*](#fig03){ref-type="fig"}). We measured T6SS killing of these matrix component mutants in competition against *P. aeruginosa*. The absence of these genes did not result in increased sensitivity to T6SS killing ([Fig. 3*B*](#fig03){ref-type="fig"}), suggesting that production of EPS rather than biofilm formation per se is the critical determining factor in the protective function of this type of T6SS armor.

![Deletion of biofilm matrix genes does not impact *V. cholerae* T6SS. (*A*) Secretion of Hcp into the supernatant (S) was measured in the *rbmA*, *rbmC*, and *bap1* mutants, and Hcp and VipA expression was measured in the cell pellet (P). (*B*) Competition between *P. aeruginosa* PAO1 and T6SS^+^ V52 and *rbmA*, *rbmC*, and *bap1* mutants. Data represent the mean ± SD of three biological replicates.](pnas.1808469115fig03){#fig03}

Because deletions of genes responsible for EPS biosynthesis resulted in susceptibility to T6SS-mediated killing, we evaluated whether mutations that modulate EPS gene expression could correspondingly change sensitivity to those attacks. In *V. cholerae* strain MO10 (O139 serotype), deletion of the core flagellin gene *flaA* results in increased EPS production, while deletion of sodium motor gene *motX* suppresses EPS expression ([@r39]). However, in V52 (O37 serotype), deletion of *flaA* had a minimal effect on the expression of EPS biosynthesis genes *vpsA* and *vpsL* ([Fig. 4*A*](#fig04){ref-type="fig"}) and, correspondingly, no significant effect on the sensitivity to killing by *P. aeruginosa* ([Fig. 4*B*](#fig04){ref-type="fig"}). In contrast, deletion of *motX* reduced EPS gene expression by approximately fourfold ([Fig. 4*A*](#fig04){ref-type="fig"}), which resulted in a corresponding increase in sensitivity to *P. aeruginosa* T6SS-mediated killing ([Fig. 4*B*](#fig04){ref-type="fig"}).

![Up- or down-regulation of EPS genes result in corresponding increase or decrease in resistance to T6SS-dependent killing. (*A*) Expression of EPS production genes *vpsA* and *vpsL* in *flaA* and *motX* mutants of *V. cholerae* V52 were measured by qRT-PCR. (*B*) *P. aeruginosa* PAO1 was competed against T6SS^+^ V52 and T6SS^−^ V52 *vasK* with no additional mutations, deletion of *vpsA*, deletion of *flaA*, or deletion of *motX*. (*C*) Expression of *vpsA* and *vpsL* genes required for EPS production in *flaA* and *motX* mutants of *V. cholerae* 2740-80 were measured by qRT-PCR. (*D*) *P. aeruginosa* PAO1 was competed against T6SS^+^ 2740-80 and T6SS^−^ 2740-80 *vipA* with no additional mutations, deletion of *vpsA*, deletion of *flaA*, deletion of *flaA vpsA*, or deletion of *motX.* Data represent the mean ± SD of three biological replicates. Student's *t* test was performed to compare each condition (ns, *P* \> 0.05; \**P* ≤ 0.05; \*\**P* ≤ 0.01; \*\*\**P* ≤ 0.001, \*\*\*\**P* ≤ 0.0001).](pnas.1808469115fig04){#fig04}

Because EPS gene regulation may be fundamentally different in strain V52 compared with that previously reported for strain MO10, we also analyzed *V. cholerae* O1 El Tor strain 2740-80. This O1 *V. cholerae* strain is more closely related to the O139 strain MO10 ([@r40]) but still has a constitutively active T6SS ([@r41]). In this strain, deletion of *flaA* resulted in an approximately fourfold up-regulation of *vpsA* and *vpsL* genes. Deletion of *motX* in this strain resulted in an approximately eightfold down-regulation of *vpsA* and twofold down-regulation of *vpsL* ([Fig. 4*C*](#fig04){ref-type="fig"}). Like strain V52, deletion of *vpsA* in 2740-80 increased its sensitivity to *P. aeruginosa* T6SS ([Fig. 4*D*](#fig04){ref-type="fig"}). However, unlike in V52, deletion of *flaA* in 2740-80 resulted in a significant increase in resistance to *P. aeruginosa* T6SS ([Fig. 4*D*](#fig04){ref-type="fig"}). Deletion of *vpsA* in the *flaA* deletion background suppressed this effect in 2740-80 ([Fig. 4*D*](#fig04){ref-type="fig"}), confirming that the increased resistance to *P. aeruginosa* T6SS was indeed due to increased *vps* gene expression. We conclude that different genetic modules controlling the level of EPS production allow for tuning of the level of resistance to T6SS attacks by heterologous bacterial species.

Discussion {#s2}
==========

Biofilms are a known mode of defense used by bacteria to protect themselves from attacks by biological predators such as eukaryotic protists and macrophages ([@r42]), prokaryotic organisms such as bdellovibrios ([@r43]), and myxococci ([@r44], [@r45]) and bacteriophages ([@r46]). It is also appreciated that bacterial biofilms are more resistant to noxious small and macromolecules, including antimicrobial substances such as antibiotics, bacteriocins, and host antimicrobial peptides and proteins (e.g., defensins and complement) ([@r47], [@r48]). Although biofilms play a role in allowing bacterial prey cells to resist these exogenous attacks, it is not clear which components of the biofilm provide resistance and how these mechanistically work. Here we show that the EPS that *V. cholerae* produces to drive biofilm formation also blocks the lethal activity of the dynamic antimicrobial T6SS when expressed by nearby predatory cells. For this reason, we propose that EPS is a type of armor that can repel T6SS attacks even when bacteria are not embedded in fully developed biofilms.

In *V. cholerae*, production and secretion of EPS is the first step in biofilm formation, as cells switch from a motile planktonic state to being nonmotile and surface-attached. Because T6SS is a contact-dependent system---its activity is only manifested among cells on a solid surface ([@r6], [@r7])---the timing of EPS production coincides precisely with when T6SS activity becomes relevant within the bacterial population.

It has been previously reported that the physical cell-to-cell distance of adjacent cells changes during biofilm formation ([@r36], [@r49]). However, we found that EPS produced by *V. cholerae* functions as a barrier against T6SS attack without interfering with the production or function of the T6SS in attacking other bacteria. This unidirectional defense means that the protective capacity of EPS is not mediated by creating physical distance, because that would diminish T6SS activity of both the predator and the prey. Because EPS armor is equally effective in blocking different T6SS effectors with varying enzymatic activities from multiple different species, our data suggest that it acts as a physical barrier, preventing penetration of the outermembrane by exogenous T6SS attacks rather than providing intrinsic resistance to any specific effector activity.

The question thus becomes, how can a physical obstruction act as a unidirectional barrier? Visualization of EPS through fluorescence labeling ([@r36]) and electron microscopy ([@r50]) suggest that EPS forms a relatively uniform coating around clusters of EPS-producing cells. Thus, the defensive properties of the EPS likely involve the macromolecular structure of the EPS matrix rather than the localization of EPS. At present, the structural organization of EPS is not known, but we can envision a couple of ways in which its geometric structure could confer a unidirectional protection against T6SS. For example, if the polymer structure of EPS consists of open channels perpendicular to the surface of the EPS producer, then the ability to mechanically block exogenous attacks might be dependent on the angle of such attacks ([Fig. 5 *A* and *B*](#fig05){ref-type="fig"}). Such a structure would allow for a T6SS apparatus perpendicular to the cellular surface to pass out of the predatory cell unobstructed. So, while all T6SS attacks by the EPS-producing predator will be unimpeded, only a small subset of exogenous attacks from a heterologous T6SS^+^ predatory cell will have a direct path to penetrate the cell envelope of the EPS producer. Alternatively, the EPS could consist of a solid coating of the cellular surface with small gaps in the covering, analogous to arrow slits in a castle wall ([Fig. 5 *A* and *C*](#fig05){ref-type="fig"}). In this model, the EPS-producing cell would need to localize the construction of its T6SS apparatus to the site of gaps in the EPS covering by coordinating EPS production with secretion machine assembly. Such coordination would have precedents, as other biopolymers, such as pili and flagella, are assembled and secreted in highly localized fashions ([@r51], [@r52]). In *V. cholerae*, its polar flagellum is even coated by a sheath that appears to be an extension of the outermembrane complete with lipopolysacchride components. Thus, either by chance or design, some T6SS apparatuses of a predatory cell might fire through gaps in the EPS armor that otherwise present a difficult to penetrate, protected surface to random exogenous attacks.

![Model for EPS-mediated T6SS armor. (*A*) In the absence of EPS, both endogenous and exogenous T6SS attacks go unimpeded. (*B*) In this model, openings in the EPS are perpendicular to the cell surface, allowing all endogenous outward attacks to be unobstructed while only allowing a small subset of exogenous inward attacks through. (*C*) In this model, the EPS armor is a solid covering of the cell surface with small gaps analogous to castle wall arrow slits. Each individual T6SS apparatus is built specifically at these gaps to allow unobstructed endogenous outward T6SS activity, while exposing only a small surface area to exogenous inward attack.](pnas.1808469115fig05){#fig05}

When *A. baylyi* acts as the predator, EPS^--^ *V. cholerae* cells are 10 times more susceptible to killing than EPS^+^ *V. cholerae* ([Fig. 2*B*](#fig02){ref-type="fig"}). This is in contrast to *P. aeruginosa*, in which the EPS^--^ *V. cholerae* cells are 100-fold more susceptible ([Fig. 2*C*](#fig02){ref-type="fig"}). One explanation for this difference could be differences in bacterial cell geometry. For example, *A. baylyi* cells are smaller than *V. cholerae* and nearly coccoid in shape, which might allow it to fire its T6SS apparatus more efficiently and overcome the EPS barrier of neighboring prey. Alternatively, this difference in the efficacy of the EPS armor could be due to differences in the T6SS apparatus of the respective predator species (e.g., T6SS structure length, mechanical force generated by the contraction event, "sharpness" of the associated PAAR proteins, and so forth). In this study, we also observed that changes in EPS gene expression result in a commensurate increase and decrease in protection against T6SS attacks, opening the door for fine-tuning the sensitivity of a given bacterium to T6SS depending on the prey and predators it encounters during its natural ecology or while receiving other signals for T6SS expression, DNA uptake, or biofilm formation ([@r53]).

Although EPS is a component of biofilm, the T6SS armor effect of EPS does not require formation of a complete biofilm, as deletion of other biofilm matrix components did not affect sensitivity to T6SS attacks ([Fig. 3*B*](#fig03){ref-type="fig"}). Thus, the role of EPS in regulating bacterial interactions may be driven more by the properties of this polysaccaride when surrounding individual bacteria, rather than its role in creating a matrix for a multicellular structurally sound biofilm. In this regard, it is interesting to note that capsular polysaccharides ([@r54]), slime layers ([@r55]), long O-side chains of some lipopolysaccharides ([@r56]), and S-layer protein arrays ([@r57]) are extracellular components of bacterial cells that are generally thought to provide individual cells with protection from phagocytic cells and macromolecular complexes, such as the complement membrane attack complex and bacteriophages through primarily mechanical exclusion. The results reported here suggest that some of these surface structures might also impede efficient T6SS-mediated attacks by mechanisms similar to those observed for EPS and *V. cholerae*. Thus, the virulence-enhancing properties of these myriad surface structures could also reflect a role they might play in providing resistance to T6SS attacks emanating from members of the commensal microbiota. Given the prevalence of the T6SS in gut microbial communities ([@r58], [@r59]), EPS production and other T6SS defense mechanisms are likely to be key factors that regulate the interplay between different microbial species and should be considered when developing antimicrobials or other biological therapies, including vaccines and probiotics.

Materials and Methods {#s3}
=====================

Bacterial Strains and Growth Conditions. {#s4}
----------------------------------------

All strains and plasmids used in this study are listed in [*SI Appendix*, Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1808469115/-/DCSupplemental). Strains were grown in LB (10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride) at 37 °C with shaking at 300 rpm. Antibiotic concentrations that were used include: streptomycin (100 µg mL^−1^), irgasan (5 µg mL^−1^), gentamicin (15 µg mL^−1^), chloramphenicol (*E. coli*, 20 µg mL^−1^; *V. cholerae*, 5 µg mL^−1^), and kanamycin (50 µg mL^−1^).

Construction of Deletions in *V. cholerae*. {#s5}
-------------------------------------------

In-frame deletions in *V. cholerae* were constructed using allelic exchange with the suicide vectors pWM91 and pDS132, as previously described ([@r5]). All cloning constructs were verified by sequencing.

Biofilm Formation in Microtiter Plates. {#s6}
---------------------------------------

Biofilm formation was assayed as previously described with some slight modifications ([@r60]). *V. cholerae* strains were grown overnight in LB with 100 µg mL^−1^ streptomycin. Following overnight growth, strains were diluted to final OD~600~ = 0.05 and 100 µL was inoculated into a single well of a polystyrene 96-well microtiter dish. The plates were incubated at 30 °C for 24 h then rinsed three times in Milli-Q water and dried at room temperature for 30 min. Each well was stained by the addition of 125 μL of 0.1% crystal violet for 15 min, followed by four to six rinses of each well in Milli-Q water. Crystal violet in each well was then solubilized in 150 μL 30% acetic acid. Then, 100 μL of the solubilized crystal violet was transferred to a new plate and the absorbance at 550 nm was measured using a plate reader (Bio-Tek).

Bacterial Killing Assay. {#s7}
------------------------

Overnight cultures of *V. cholerae*, *E. coli*, *A. bayli*, and *P. aeruginosa* were diluted 100:1 in LB and grown at 37 °C until mid-log (OD~600~ = 0.6--0.8). Cultures were centrifuged at 8,000 × *g* for 5 min and resuspended in LB to final concentration of OD~600~ = 10. Competition assays were set up at predator-to-prey ratio of 1:1 and incubated on LB agar plates at 37 °C for 2 h (*V. cholerae* vs. *V. cholerae*, *V. cholerae* vs. *A. bayli* ADP1, and *V. cholerae* vs. *E. coli* competitions) or 3 h (*V. cholerae* vs. *P. aeruginosa* competitions). For competitions involving the VgrG3-NucSe1 effector, the predator-to-prey ratio was increased to 10:1. Following incubation, mixtures were resuspended in 1 mL LB. Serial dilutions were spotted on plates to select for prey strains and CFUs counted. Three to six biological replicates were performed.

Western Blots on Supernatant and Cell Lysate. {#s8}
---------------------------------------------

Overnight cultures of *V. cholerae* were diluted 100:1 in LB and grown shaking at 37 °C until mid-log (OD~600~ = 0.6--0.8). A 1-mL culture was centrifuged at 8,000 × *g* for 5 min and resuspended in 125 μL LB. Cells were incubated at room temperature for 15 min and centrifuged again. Next, 75 μL of the supernatant was removed and added to 25 μL 4× SDS buffer and boiled at 95 °C for 10 min. The pellet was resuspended to OD~600~ = 10 in 1× SDS buffer and boiled at 95 °C for 10 min. Following brief cooling on ice, proteins were separated by SDS/PAGE. Following transfer on a nitrocellulose membrane (iBlot2; Invitrogen), the membranes were blotted for VipA and Hcp, respectively (Rabbit, peptide anti-Hcp and anti-VipA antibody; Genescript). A fluorescent secondary antibody (Li-Cor IRDye 680RD) was used for detection and membranes were imaged using a Li-Cor Odyssey Blot Imager (Li-Cor Biotechnology).

RNA Extraction and qRT-PCR. {#s9}
---------------------------

Overnight cultures of *V. cholerae* were diluted 100:1 in LB and grown at 30 °C shaking at 200 rpm for 5 h, as previously described with some modifications ([@r61]). Next, 2 mL of each culture was centrifuged and resuspended in 1 mL TRIzol (Thermo Fisher Scientific). RNA was extracted using a kit according to the manufacturer's instructions (Ambion) and each sample was treated with Turbo DNA-free kit to remove any contaminating DNA (Ambion). RNA was quantified by nanodrop (Thermo-Fisher Scientific), and qRT-PCR reactions were set up using Kapa SYBR Fast One-Step Universal qRT MasterMix and run on a thermocycler (Eppendorf Mastercycler RealPlex2). RNA levels were normalized to that of gyrA for each strain. At least three biological replicates were performed for each experiment.

Statistical Analysis. {#s10}
---------------------

Statistical tests were performed using by Student's *t* test with Prism (Graphpad Software). All data presented are the mean ± SD.
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